# US 2024/0390553 A1 · Meshed dermal tissue matrix products

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0390553 A1
- Document ID: US20240390553A1
- Status: Published application
- Kind: A1
- Application number: 18/619,327
- Filed: 2024-03-28
- Published: 2024-11-28
- Earliest claimed: 2019-02-06
- Assignees: LifeCell Corporation
- Applicants: LifeCell Corporation
- Inventors: Hui Xu; Sangwook Park; Melissa Richter Bowley
- Web page: https://patentgrep.com/patent/US20240390553A1

## CPC

- A61L 27/36: containing ingredients of undetermined constitution or reaction products thereof {, e.g. transplant tissue, natural bone, extracellular matrix (isolated natural compounds, e.g. collagen A61L27/24)}
- A61L 27/362: {Skin, e.g. dermal papillae}
- A61B 17/06166: {Sutures (suture materials A61L17/00; manufacture of artificial threads D01D; treatment of threads D06M)}
- A61F 2/12: Mammary prostheses
- A61L 27/3633: {Extracellular matrix [ECM]}
- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 31/005: {Ingredients of undetermined constitution or reaction products thereof}
- A61F 2002/0068: {having a special mesh pattern}
- A61F 2002/0081: {directly machined on the prosthetic surface, e.g. holes, grooves (A61F2/30771 takes precedence)}
- A61F 2210/0057: stretchable
- A61F 2220/0008: Fixation appliances for connecting prostheses to the body
- A61L 2430/04: for mammary reconstruction
- A61L 2430/34: for soft tissue reconstruction
- A61N 1/362: Heart stimulators (heart defibrillators A61N1/39)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

The present disclosure provides meshed acellular dermal tissue matrix compositions, devices, and methods of use. The meshed devices can be used in conjunction with a variety of implants such as breast implants or tissue expanders.

## Claims

### Claim 1

A tissue product, comprising:
an acellular dermal matrix formed as an expandable sheet comprising a plurality of slits having a long axis, the slits extending through a thickness of the sheet and arranged in a pattern forming a mesh configuration, each slit ranging in length from about 5 mm to 7.5 mm, and the distance between each slit along the long axis of the slits ranging in length from 2.5 mm to 5 mm; and
wherein the mesh configuration allows for regenerative tissue ingrowth while reducing scar tissue formation.

### Claim 2 (depends on 1)

The tissue product of claim 1, wherein the mesh configuration has a predetermined length:distance ratio of the length of each slit to the distance between slits along the long axis of the slits, the length:distance ratio ranging from about 1:1 to about 3:1.

### Claim 3 (depends on 1)

The tissue product of claim 1, wherein the mesh configuration is configured to distribute tension across a curved surface when the acellular dermal matrix is applied to a soft tissue.

### Claim 4 (depends on 1)

The tissue product of claim 1, wherein the mesh configuration is configured to allow for the drainage of fluid from around the acellular dermal matrix to facilitate resorption of blood or serous fluid.

### Claim 5 (depends on 1)

The tissue product of claim 1, wherein the mesh configuration is configured to allow for expansion of the acellular dermal matrix to provide greater surface area coverage of an implant.

### Claim 6 (depends on 1)

The tissue product of claim 1, wherein the plurality of slits are oriented orthogonal to a long axis of the matrix.

### Claim 7 (depends on 1)

The tissue product of claim 1, wherein the plurality of slits are oriented parallel to a long axis of the matrix.

### Claim 8

A method of treating tissue, comprising;
selecting a meshed acellular dermal matrix formed as an expandable sheet comprising a plurality of slits having a long axis, the slits extending linearly through a thickness of the sheet and arranged in a pattern forming a mesh configuration, each slit ranging in length from about 5 mm to 7.5 mm, the distance between each slit along the long axis ranging in length from 2.5 mm to 5 mm;
preparing a recipient site in a body within or contacting a soft tissue; and
securing at least a portion of the meshed acellular dermal matrix to the recipient site.

### Claim 9 (depends on 8)

The method of claim 8, wherein the meshed acellular dermal matrix sheet is expanded to cover or retain a tissue implant or anatomic structure.

### Claim 10 (depends on 8)

The method of claim 8, wherein the meshed acellular dermal matrix sheet is flexible and curved around an implant.

### Claim 11 (depends on 8)

The method of claim 8, further comprising securing at least a portion of a second acellular tissue matrix product to the recipient site.

### Claim 12 (depends on 11)

The method of claim 11, wherein the second acellular tissue matrix product is a three-dimensional formed tissue matrix product.

### Claim 13 (depends on 8)

The method of claim 8, further comprising implanting a tissue expander to the recipient site.

### Claim 14 (depends on 13)

The method of claim 13, wherein the tissue expander comprises a silicone or saline filled implant.

### Claim 15 (depends on 8)

The method of claim 8, wherein the meshed acellular dermal matrix has an epithelial basement membrane across a surface of the meshed acellular dermal matrix.

### Claim 16 (depends on 1)

The tissue product of claim 1, further comprising a breast implant or tissue expander coupled to the meshed acellular dermal matrix.
